Header

UZH-Logo

Maintenance Infos

Pelvic exenterations for advanced and recurrent endometrial cancer: clinical outcomes of 40 patients


Schmidt, Ana-Maria; Imesch, Patrick; Fink, Daniel; Egger, Herwig (2016). Pelvic exenterations for advanced and recurrent endometrial cancer: clinical outcomes of 40 patients. International Journal of Gynecological Cancer, 26(4):716-721.

Abstract

OBJECTIVE The aim of this study was to analyze the clinical experience and outcome of patients who have undergone pelvic exenteration for primary advanced or recurrent endometrial cancer.
METHODS We analyzed the medical records of 40 women who underwent pelvic exenteration to treat primary advanced or recurrent endometrial cancer.
RESULTS Pelvic exenteration was performed in 40 patients with primary advanced or recurrent endometrial cancer. Three patients (8%) underwent a primary exenteration, and 37 patients (92%) underwent a secondary exenteration. A total exenteration, anterior exenteration, and posterior exenteration was performed in 85%, 5%, and 10% of patients, respectively.In 31 cases, exenteration was performed with a curative aim, and in 9 cases, exenteration was performed with a palliative aim. The overall survival rates were 61.4% at 5 years and 51.1% at 10 years. For the 31 patients who underwent pelvic exenteration with a curative aim, the overall survival rates were higher than those for the entire study population and were 72.6% at 5 years and 59.4% at 10 years. For the 9 patients who underwent a palliative exenteration, the overall survival rates were 19.1% at 5 years and 0% at 10 years. This is to the best of our knowledge the biggest study of pelvic exenteration in patients with endometrial cancer.
CONCLUSIONS Our data show that pelvic exenterations are a valid therapeutic option with long-term survival in select patients.

Abstract

OBJECTIVE The aim of this study was to analyze the clinical experience and outcome of patients who have undergone pelvic exenteration for primary advanced or recurrent endometrial cancer.
METHODS We analyzed the medical records of 40 women who underwent pelvic exenteration to treat primary advanced or recurrent endometrial cancer.
RESULTS Pelvic exenteration was performed in 40 patients with primary advanced or recurrent endometrial cancer. Three patients (8%) underwent a primary exenteration, and 37 patients (92%) underwent a secondary exenteration. A total exenteration, anterior exenteration, and posterior exenteration was performed in 85%, 5%, and 10% of patients, respectively.In 31 cases, exenteration was performed with a curative aim, and in 9 cases, exenteration was performed with a palliative aim. The overall survival rates were 61.4% at 5 years and 51.1% at 10 years. For the 31 patients who underwent pelvic exenteration with a curative aim, the overall survival rates were higher than those for the entire study population and were 72.6% at 5 years and 59.4% at 10 years. For the 9 patients who underwent a palliative exenteration, the overall survival rates were 19.1% at 5 years and 0% at 10 years. This is to the best of our knowledge the biggest study of pelvic exenteration in patients with endometrial cancer.
CONCLUSIONS Our data show that pelvic exenterations are a valid therapeutic option with long-term survival in select patients.

Statistics

Citations

1 citation in Web of Science®
1 citation in Scopus®
Google Scholar™

Altmetrics

Downloads

11 downloads since deposited on 16 Feb 2017
11 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Gynecology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:May 2016
Deposited On:16 Feb 2017 08:30
Last Modified:01 May 2017 00:01
Publisher:Lippincott Williams & Wilkins
ISSN:1048-891X
Additional Information:For accepted manuscript: This is a non-final version of an article published in final form in Schmidt, Ana-Maria; Imesch, Patrick; Fink, Daniel; Egger, Herwig (2016). Pelvic exenterations for advanced and recurrent endometrial cancer: clinical outcomes of 40 patients. International Journal of Gynecological Cancer, 26(4):716-721.
Publisher DOI:https://doi.org/10.1097/IGC.0000000000000678
PubMed ID:26937752

Download

Preview Icon on Download
Preview
Content: Accepted Version
Filetype: PDF
Size: 189kB
View at publisher
Preview Icon on Download
Preview
Content: Published Version
Filetype: PDF
Size: 193kB